|
|
|
|
|
|
[¼ö»ó]±è¿µÃ¶ ±³¼ö, Æó¾ÏÇÐȸ ¿ì¼ö³í¹® Çмú»ó |
|
|
|
ȼøÀü³²´ëº´¿ø È£Èí±â³»°ú ±è¿µÃ¶ ±³¼ö°¡ 6¿ù 25ÀÏ(±Ý) °æÁÖ Çö´ëÈ£ÅÚ¿¡¼ ¿¸° '2010³â ´ëÇÑÆó¾ÏÇÐȸ Ãá°èÇмú´ëȸ'¿¡¼ 'Æó¾Ï »óÇǼ¼Æ÷ ¼ºÀåÀÎÀÚ ¼ö¿ëü(EGFR) À¯ÀüÀÚÀÇ T790M º¯ÀÌ¿¡ ÀÇÇÑ ¾àÁ¦ ³»¼ºÀ» ±Øº¹ÇÒ ¼ö ÀÖ´Â Erlotinib°ú Ç×¾ÏÈÇоàÁ¦ÀÇ º´ÇÕ¹æ¹ý (Combining Erlotinib with Cytotoxic Chemotherapy May Overcome Resistance Caused by T790M Mutation of EGFR Gene in Non-Small Cell Lung Carcinoma)' ÁÖÁ¦ÀÇ ³í¹®ÀÌ ¿ì¼ö³í¹®À¸·Î ¼±Á¤µÅ Çмú»óÀ» ¼ö»óÇß´Ù.
|
|
|
|
|
|
|
|
|
|
|